1Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
2Department of Pharmaceutics and Technological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
BibTex Citation Data :
@article{JKSA78693, author = {Ayu Shalihat and Cecep Suhandi and Aliya Nur Hasanah and Mutakin Mutakin}, title = {In Silico Study of Organo-selenium with PPAR-γ and NF-κB Receptors for Cardiovascular Protection}, journal = {Jurnal Kimia Sains dan Aplikasi}, volume = {29}, number = {1}, year = {2026}, keywords = {Cardio-protection; molecular docking; molecular dynamic; organo-selenium, PPAR-γ, NF-κB.}, abstract = {Cardiovascular disease (CVD) continues to represent a significant global health challenge, leading to the need for new and more effective therapeutic approaches. Organo-selenium compounds have potential as antioxidants and anti-inflammatory agents, which may help protect the heart and vascular system. However, the molecular mechanisms by which Organo-selenium exerts its cardioprotective effects are still not fully understood. The interaction with key regulatory pathways such as peroxisome proliferator-activated receptor gamma (PPAR-γ) and nuclear factor kappa B (NF-κB) has not been clearly defined. Therefore, this study aims to investigate the molecular interactions between organo-selenium compounds and the PPAR-γ and NF-κB-inducing kinase receptors in the context of cardiovascular protection. Molecular docking simulations were performed using the ligand-binding domain of PPAR-γ and the 20 organo-selenium ligands. The binding affinities and interactions between organo-selenium and receptors were analyzed. Among the screened organo-selenium ligands, compound 13 exhibited the most favorable binding affinity toward both PPAR-γ and NF-κB compared to the native ligand. Based on these results, compound 13 was selected for molecular dynamics simulations. The molecular dynamics study, using parameters such as RMSD, RMSF, SASA, and the Gyration plot, shows that compound 13 with PPAR-γ exhibits better stability and flexibility. At the same time, the NF-κB interaction, though stable, may be less energetically favorable than the native ligand. These interactions suggest that compound 13 (Ebselen) may modulate PPAR-γ activity, thereby influencing cell signaling pathways involved in cardiac protection. Overall, the findings suggest that modulation of the PPAR-γ pathway by compound 13 may represent a promising mechanism in cell signaling for cardiovascular protection.}, issn = {2597-9914}, pages = {30--38} doi = {10.14710/jksa.29.1.30-38}, url = {https://ejournal.undip.ac.id/index.php/ksa/article/view/78693} }
Refworks Citation Data :
Article Metrics:
Last update:
Last update: 2026-09-30 02:32:04
As an article writer, the author has the right to use their article for various purposes, including use by institutions that employ the author or institutions that provide funding for the research. These author rights are granted without special permission.
Authors who publish a paper in JKSA have broad rights to use their work for teaching and scientific purposes without the need to request permission, including: (i) teaching in the author's class or institution; (ii) presenting the work at meetings or conferences and distributing copies to participants; (iii) using the work in training conducted by the author or the author's institution; (iv) distributing copies to colleagues for research purposes; (v) using the work in the compilation of subsequent works by the author; (vi) including the work in a thesis or dissertation; (vii) reusing part of the article in another work, with appropriate citation; (viii) preparing derivative works, with appropriate citation; and (ix) voluntarily posting the work on open websites operated by the author or the author's institution for scientific purposes, in accordance with the CC BY-SA License.
Authors and readers may copy and redistribute the material in any medium or format, and may remix, transform, and build upon the material for any purpose, provided that they give appropriate credit by citing the article or its content, provide a link to the license, and indicate if changes were made.
The authors submitting a manuscript do so on the understanding that, if accepted for publication, the copyright of the article shall be assigned to Jurnal Kimia Sains dan Aplikasi (JKSA). Copyright encompasses the rights to reproduce and distribute the article in all forms and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations.
Reproducing any part of this journal, storing it in a database, or transmitting it in any form or medium is permitted without written permission from JKSA. However, the original source must be properly cited in accordance with academic conventions.
JKSA, the Chemistry Department of Diponegoro University, and the Editor make every effort to ensure that no inaccurate, false, or misleading data, opinions, or statements are published in JKSA. However, the content of each article is the sole and exclusive responsibility of its authors.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form - Indonesian] [Copyright Transfer Form - English]. The copyright form should bear the authors' original signatures and be sent to the Editor as a printed document, a scanned document sent via email, or by fax.
Prof. Adi Darmawan, Ph.D (Editor in Chief)
Editor in chief of Jurnal Kimia Sains dan Aplikasi (JKSA)
Chemistry Department, Faculty of Sciences and Mathematics, Diponegoro University
Visitor: View My Stats
Jurnal Kimia Sains dan Aplikasi is indexed in:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.